Medicine for treating bone diseases

A drug and bone disease technology, applied in the field of drugs for the treatment of rheumatic bone disease, can solve the problems of inability to eradicate, poor efficacy, easy to cause side effects, etc., and achieve the effects of short curative effect, no toxic side effects, and scientific and reasonable formula

Active Publication Date: 2017-06-27
于洪波
View PDF3 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0012] At present, Western medicine is mostly used to treat bone disease clinically. The curative effect is not good, it cannot be eradicated, and it is easy to cause side effects. There is no drug that can effectively treat bone disease.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] Embodiment 1, a kind of medicine for the treatment of bone disease, is made by the raw material ratio of following parts by weight: 15 parts of piercing stone, 20 parts of turmeric, 30 parts of oyster, 10 parts of dried blood, 10 parts of sumac, 15 parts of angelica , 15 parts of old paper, 20 parts of Wujiapi, 15 parts of Zou Ma Feng, and 10 parts of licorice.

Embodiment 2

[0019] Embodiment 2, a kind of medicine for treating bone disease, is made by the raw material ratio of following parts by weight: Chuanchuangshi, 20 parts, 25 parts of turmeric, 40 parts of oyster, 10 parts of blood, 15 parts of sumac, 20 parts of angelica 15 parts of old paper, 20 parts of Wujiapi, 15 parts of Zou Ma Feng, and 8 parts of licorice.

Embodiment 3

[0020] Embodiment 3, a kind of medicine for treating bone disease, is made by the raw material ratio of following parts by weight: 25 parts of piercing stone, 20 parts of turmeric, 50 parts of oyster, 15 parts of blood, 25 parts of sumac, 30 parts of angelica , 20 parts of old paper, 15 parts of Wujiapi, 10 parts of Zou Ma Feng, and 10 parts of licorice.

[0021] Preparation method: The above-mentioned medicines are made into decoction according to conventional techniques.

[0022] Dosage: 1 dose each time, 2 times a day, 30 days as a course of treatment.

[0023] Treatment results:

[0024] Refer to the "Diagnostic and Curative Criteria for Syndromes of Traditional Chinese Medicine":

[0025] 1. Cure: recovery from illness: symptoms disappear, no recurrence within one year.

[0026] 2. Effective: After treatment, the symptoms were significantly improved.

[0027] 3. Ineffective: There is no change in the condition before and after the symptomatic treatment.

[0028] Obse...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

Disclosed is a medicine for treating bone diseases. The medicine for treating the bone diseases is prepared from Radix Cudraniae, Rhizoma Curcumae Longae, Ostrea, Resina Draconis, Lignum Sappan, Radix Angelicae Sinensis, Fructus Psraleae, Cortex Acanthopanacis, Herba Blumeae Laciniatae and Radix Glycyrrhizae. The medicine for treating the bone diseases has the advantages that the medicine for treating the bone diseases and rheumatism is prepared from pure traditional Chinese medicines is scientific and reasonable in formula, simple to prepare without toxic and side effects and quick in action, and is remarkably effective in treatment of lumbar disc herniation, bone hyperplasia, lumbar spinal stenosis, degenerative diseases, osteoarthritis, synovial membrane effusion, numbness of limbs, leg cramp, muscle strain and bone fracture, and a cure rate is up to about 95%.

Description

technical field [0001] The invention relates to the technical field of traditional Chinese medicine, in particular to a medicine for treating rheumatic bone disease. Background technique [0002] Bone diseases generally include: rheumatoid arthritis, rheumatoid arthritis, degenerative arthritis, ankylosing spondylitis, cervical spondylosis, lumbar spondylosis, frozen shoulder, osteoarthritis, femoral head necrosis, postpartum wind, etc. [0003] Rheumatoid arthritis is a common acute or chronic inflammation of connective tissue. Can be recurrent and involve the heart. Clinical one is characterized by joint and muscle migratory soreness, heaviness, and pain. It is an allergic disease. It is one of the main manifestations of rheumatic fever, and the onset is mostly acute fever and joint pain. [0004] Rheumatoid arthritis is a chronic systemic autoimmune disease characterized by joint synovitis. Synovitis is persistent and recurrent, which can lead to the destruction of car...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/9066A61P19/08A61P19/04A61P29/00A61P19/02A61P21/00A61K35/618
CPCA61K9/0095A61K35/618A61K36/185A61K36/232A61K36/254A61K36/28A61K36/48A61K36/484A61K36/60A61K36/889A61K36/896A61K36/9066A61K2300/00
Inventor 于洪波
Owner 于洪波
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap